| Oct 30 |
Codexis Q3 2024 Earnings Preview
|
| Oct 24 |
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
|
| Oct 22 |
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
|
| Oct 15 |
Codexis announces employment inducement grants
|
| Oct 10 |
Codexis to Report Third Quarter 2024 Financial Results on October 31
|
| Oct 9 |
Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
|
| Oct 2 |
Codexis increases cash reserves; appoints Georgia Erbez as CFO
|
| Oct 2 |
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
|
| Oct 1 |
Codexis licenses Genomics Life Science enzyme portfolio to Alphazyme LLC
|
| Oct 1 |
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
|
